VISUM-HCC: Vienna survival model for hepatocellular carcinoma
| Parameter | Points | ||
|---|---|---|---|
| 0 | 1 | ||
| Bilirubin (mg/dl) | ⩽2 | >2 | |
| PT (%) | >70 | ⩽70 | |
| AFP (kU/l) | ⩽125 | >125 | |
| Tumour >50% | ⩽50% | >50% | |
| Enlarged lymph nodes | No | Yes | |
| PVT | No | Yes | |
| Stage 1: 0–2 points | Σ points2-150: | ||
| Stage 2: 3 points | |||
| Stage 3: 4–6 points | Stage2-150: | ||
PTV, portal vein thrombosis; PT, prothrombin time; AFP, α fetoprotein.
↵2-150 The sum of the points (Σ points) gives the VISUM-HCC stage of the patient.